Varian Medical Systems Inc (NYSE:VAR) had a decrease of 19.45% in short interest. VAR’s SI was 3.33 million shares in June as released by FINRA. Its down 19.45% from 4.13M shares previously. With 570,700 avg volume, 6 days are for Varian Medical Systems Inc (NYSE:VAR)’s short sellers to cover VAR’s short positions. The SI to Varian Medical Systems Inc’s float is 3.64%. The stock decreased 0.92% or $1.14 during the last trading session, reaching $122.17. About 806,293 shares traded or 19.53% up from the average. Varian Medical Systems, Inc. (NYSE:VAR) has risen 21.31% since June 18, 2017 and is uptrending. It has outperformed by 8.74% the S&P500. Some Historical VAR News: ; 25/04/2018 – VARIAN MEDICAL SYSTEMS INC SEES FY18 CASH FLOW FROM OPERATIONS RANGE OF $475 MLN TO $550 MLN; 20/04/2018 – VARIAN CALYPSO ANCHORED BEACON TRANSPONDER FOR LUNG GETS FDA; 26/03/2018 – SIRTEX REPORTS FIRB APPROVAL ON VARIAN SCHEME OF ARRANGEMENT; 22/05/2018 – VARIAN MEDICAL SYSTEMS INC VAR.N – CO IS COMMITTED TO TERMS OF VARIAN SCHEME AT PURCHASE PRICE OFFERED BY VARIAN OF A$28 PER SHARE; 22/05/2018 – SIRTEX SAYS VARIAN HAS INDICATED IT WILL STICK TO ITS PROPOSAL; 08/03/2018 Glancy Prongay & Murray LLP Commences Investigation on Behalf of Varian Medical Systems, Inc. (VAR) Investors; 26/03/2018 – varian medical systems, inc | universal cylinder applicator family, un | K172611 | 03/21/2018 |; 25/04/2018 – VARIAN MEDICAL SYSTEMS INC SEES FY18 REVENUE GROWTH RANGE OF 6 PERCENT TO 9 PERCENT, WHICH NOW INCLUDES IMPACT FROM CURRENCY FOR REMAINDER OF YEAR; 25/04/2018 – VARIAN MEDICAL SYSTEMS INC VAR.N SEES FY 2018 NON-GAAP SHR $4.43 TO $4.53; 13/03/2018 – SIRTEX MEDICAL – DRAFT SCHEME BOOKLET FOR SCHEME TO SELL CO TO VARIAN MEDICAL SYSTEMS, INC LODGED WITH ASIC ON MARCH 9
Voya Financial, Inc. (VOYA) formed multiple top with $53.37 target or 4.00% above today’s $51.32 share price. Voya Financial, Inc. (VOYA) has $8.66B valuation. The stock decreased 0.74% or $0.38 during the last trading session, reaching $51.32. About 2.28 million shares traded or 13.95% up from the average. Voya Financial, Inc. (NYSE:VOYA) has risen 53.04% since June 18, 2017 and is uptrending. It has outperformed by 40.47% the S&P500. Some Historical VOYA News: ; 30/04/2018 – Voya Global Equity Adds PNC, Exits Wells Fargo, Cuts Oracle; 11/05/2018 – VOYA FINANCIAL INC – AS PART OF DEAL, PEN-CAL WILL RE-BRAND TO VOYA; 30/04/2018 – Voya Multi-Manager Intl Equity Adds Rio Tinto, Exits RELX; 24/05/2018 – Dina Santoro Appointed to the Board of Trustees for Several of Voya Investment Management’s Funds; 18/04/2018 – Fitch Rates Voya CLO 2014-1 Ltd./LLC; Publishes New Issue Report; 14/05/2018 – FIL Adds Voya Financial, Exits Dentsply, Cuts Citigroup: 13F; 08/03/2018 – SEC Alleges Voya Advisers Recalled Loaned Securities Before Dividend Record Dates so Insurance Affiliates Could Receive Tax Benefit; 06/04/2018 – S&PGR Assigns Voya CLO 2018-1 Ltd. Notes Ratings; 29/03/2018 – Voya Prime Rate Trust (NYSE: PPR) Dividend Declaration; 04/04/2018 – BofA Finance LLC Launches Offering of Cash-Settled Equity-Linked Notes Linked to the Common Stk of Voya Fincl, Inc. Due May 1, 2023
Since February 21, 2018, it had 1 insider purchase, and 2 insider sales for $369,684 activity. Another trade for 13,900 shares valued at $698,439 was bought by Nelson Charles P. Another trade for 895 shares valued at $45,439 was made by SILVA KEVIN D on Wednesday, February 21.
Among 18 analysts covering Voya Financial (NYSE:VOYA), 14 have Buy rating, 1 Sell and 3 Hold. Therefore 78% are positive. Voya Financial had 50 analyst reports since August 26, 2015 according to SRatingsIntel. As per Thursday, November 5, the company rating was maintained by RBC Capital Markets. As per Friday, November 10, the company rating was maintained by Keefe Bruyette & Woods. Deutsche Bank maintained Voya Financial, Inc. (NYSE:VOYA) rating on Tuesday, April 17. Deutsche Bank has “Buy” rating and $66 target. The rating was maintained by Sandler O’Neill with “Buy” on Wednesday, January 10. The rating was maintained by RBC Capital Markets with “Buy” on Monday, July 10. The stock of Voya Financial, Inc. (NYSE:VOYA) earned “Market Perform” rating by Wells Fargo on Friday, September 23. As per Thursday, February 11, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating given on Thursday, December 21 by Keefe Bruyette & Woods. Morgan Stanley upgraded Voya Financial, Inc. (NYSE:VOYA) on Wednesday, November 11 to “Overweight” rating. The firm earned “Neutral” rating on Friday, July 15 by Goldman Sachs.
Investors sentiment decreased to 0.86 in Q1 2018. Its down 0.12, from 0.98 in 2017Q4. It fall, as 35 investors sold Voya Financial, Inc. shares while 132 reduced holdings. 59 funds opened positions while 84 raised stakes. 174.45 million shares or 2.58% less from 179.07 million shares in 2017Q4 were reported. Gam Holding Ag reported 11,163 shares. Jacobs Levy Equity Mngmt holds 761,820 shares. Advisory Ntwk Ltd Company reported 721 shares. Stratos Wealth Partners owns 799 shares. Point72 Asset Management Lp has invested 0.31% of its portfolio in Voya Financial, Inc. (NYSE:VOYA). Morgan Stanley accumulated 776,727 shares. Huber Capital Management Limited Liability Corp reported 0.55% stake. Old Mutual Glob (Uk) Limited invested in 19,900 shares or 0.01% of the stock. Gator Capital Mngmt Ltd Llc owns 8,125 shares. Neuberger Berman Gp Lc holds 107,969 shares or 0.01% of its portfolio. Bluecrest Cap Mngmt Ltd holds 41,123 shares or 0.06% of its portfolio. State Of New Jersey Common Pension Fund D has invested 0.1% of its portfolio in Voya Financial, Inc. (NYSE:VOYA). Mitsubishi Ufj Tru And Bk invested in 0.04% or 451,487 shares. Moreover, Chesley Taft Associates Ltd Co has 0.17% invested in Voya Financial, Inc. (NYSE:VOYA) for 38,065 shares. Korea Invest Corporation accumulated 27,510 shares or 0.01% of the stock.
Analysts await Voya Financial, Inc. (NYSE:VOYA) to report earnings on August, 7. They expect $1.09 EPS, up 62.69% or $0.42 from last year’s $0.67 per share. VOYA’s profit will be $184.02 million for 11.77 P/E if the $1.09 EPS becomes a reality. After $0.77 actual EPS reported by Voya Financial, Inc. for the previous quarter, Wall Street now forecasts 41.56% EPS growth.
Among 12 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 5 have Buy rating, 2 Sell and 5 Hold. Therefore 42% are positive. Varian Medical Systems Inc. had 39 analyst reports since August 27, 2015 according to SRatingsIntel. The rating was reinitiated by Barrington Research on Tuesday, January 12 with “Outperform”. As per Monday, May 8, the company rating was upgraded by Citigroup. RBC Capital Markets initiated it with “Sector Perform” rating and $86 target in Tuesday, December 22 report. The firm has “Hold” rating by RBC Capital Markets given on Thursday, April 26. As per Thursday, January 25, the company rating was upgraded by Barrington. RBC Capital Markets maintained it with “Hold” rating and $115.0 target in Thursday, January 25 report. Brean Capital maintained Varian Medical Systems, Inc. (NYSE:VAR) rating on Thursday, April 28. Brean Capital has “Buy” rating and $87 target. The firm has “Neutral” rating given on Monday, October 30 by Citigroup. The rating was initiated by Citigroup on Thursday, November 12 with “Neutral”. The firm has “Sector Perform” rating by RBC Capital Markets given on Monday, January 23.
Varian Medical Systems, Inc. designs, makes, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company has market cap of $11.18 billion. It operates through two divisions, Oncology Systems and Imaging Components. It has a 91.79 P/E ratio. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.
More recent Varian Medical Systems, Inc. (NYSE:VAR) news were published by: Streetinsider.com which released: “Varian Medical Systems (VAR) Informed Sirtex that it Will not be Providing Counter Proposal to CDH-CGP Offer” on June 14, 2018. Also Prnewswire.com published the news titled: “Varian Announces Third Quarter Fiscal Year 2018 Earnings Release Date” on June 11, 2018. Streetinsider.com‘s news article titled: “Form 8-K VARIAN MEDICAL SYSTEMS For: Jun 14” with publication date: June 14, 2018 was also an interesting one.